| Dr Rhondey Ian O'brien Harford, MD | |
|
4518 Union Deposit Rd, Harrisburg, PA 17111-2921 | |
| (717) 652-5840 | |
| (717) 652-8152 |
| Full Name | Dr Rhondey Ian O'brien Harford |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 4518 Union Deposit Rd, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821084724 | NPI | - | NPPES |
| 001841610 | Medicaid | PA | |
| P00757174 | Other | PA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD073812L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Reading, PA | Hospital |
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
| Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
By combining a gold nanoparticle with a unique family of nucleic acids, researchers at Northwestern University have created a new type of intracellular reporting system that with a flash of light reveals the presence and quantity of a wide variety of biologically important molecules. These so-called nanoflares could provide cancer biologists with a highly sensitive method of tracking complex biochemical processes in real time without interfering with those processes.
The U.S. Food and Drug Administration announced today that certain tobacco products introduced or changed after Feb. 15, 2007 must be reviewed by the agency. In FDA guidance published today, the agency outlines a pathway for marketing a product whereby the company marketing the product must prove that it is "substantially equivalent" to products commercially available on Feb. 15, 2007.
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
"Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers," USA Today reports. "Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.
› Verified 3 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
By combining a gold nanoparticle with a unique family of nucleic acids, researchers at Northwestern University have created a new type of intracellular reporting system that with a flash of light reveals the presence and quantity of a wide variety of biologically important molecules. These so-called nanoflares could provide cancer biologists with a highly sensitive method of tracking complex biochemical processes in real time without interfering with those processes.
The U.S. Food and Drug Administration announced today that certain tobacco products introduced or changed after Feb. 15, 2007 must be reviewed by the agency. In FDA guidance published today, the agency outlines a pathway for marketing a product whereby the company marketing the product must prove that it is "substantially equivalent" to products commercially available on Feb. 15, 2007.
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
"Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers," USA Today reports. "Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.
› Verified 3 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
By combining a gold nanoparticle with a unique family of nucleic acids, researchers at Northwestern University have created a new type of intracellular reporting system that with a flash of light reveals the presence and quantity of a wide variety of biologically important molecules. These so-called nanoflares could provide cancer biologists with a highly sensitive method of tracking complex biochemical processes in real time without interfering with those processes.
The U.S. Food and Drug Administration announced today that certain tobacco products introduced or changed after Feb. 15, 2007 must be reviewed by the agency. In FDA guidance published today, the agency outlines a pathway for marketing a product whereby the company marketing the product must prove that it is "substantially equivalent" to products commercially available on Feb. 15, 2007.
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
"Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers," USA Today reports. "Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.
› Verified 3 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
By combining a gold nanoparticle with a unique family of nucleic acids, researchers at Northwestern University have created a new type of intracellular reporting system that with a flash of light reveals the presence and quantity of a wide variety of biologically important molecules. These so-called nanoflares could provide cancer biologists with a highly sensitive method of tracking complex biochemical processes in real time without interfering with those processes.
The U.S. Food and Drug Administration announced today that certain tobacco products introduced or changed after Feb. 15, 2007 must be reviewed by the agency. In FDA guidance published today, the agency outlines a pathway for marketing a product whereby the company marketing the product must prove that it is "substantially equivalent" to products commercially available on Feb. 15, 2007.
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
"Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers," USA Today reports. "Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rhondey Ian O'brien Harford, MD 4518 Union Deposit Rd, Harrisburg, PA 17111-2921 Ph: (717) 652-5840 | Dr Rhondey Ian O'brien Harford, MD 4518 Union Deposit Rd, Harrisburg, PA 17111-2921 Ph: (717) 652-5840 |
News Archive
By combining a gold nanoparticle with a unique family of nucleic acids, researchers at Northwestern University have created a new type of intracellular reporting system that with a flash of light reveals the presence and quantity of a wide variety of biologically important molecules. These so-called nanoflares could provide cancer biologists with a highly sensitive method of tracking complex biochemical processes in real time without interfering with those processes.
The U.S. Food and Drug Administration announced today that certain tobacco products introduced or changed after Feb. 15, 2007 must be reviewed by the agency. In FDA guidance published today, the agency outlines a pathway for marketing a product whereby the company marketing the product must prove that it is "substantially equivalent" to products commercially available on Feb. 15, 2007.
According to a study recently accepted for publication by Environmental Health Perspectives, researchers found no correlation between specific human health effects in "watermen" (commercial fishermen) and low-level exposure to the dinoflagellate Pfiesteria in areas of the Chesapeake Bay.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
"Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers," USA Today reports. "Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.
› Verified 3 days ago
David Choi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4520 Union Deposit Rd, Harrisburg, PA 17111 Phone: 717-531-4094 Fax: 717-531-0136 | |
Christopher Haskins, Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-724-6740 Fax: 717-724-6741 | |
Brian P Bloom, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4520 Union Deposit Rd, Harrisburg, PA 17111 Phone: 717-652-6105 Fax: 717-652-8152 | |
Dr. David C Weksberg, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Londonderry Rd Lowr Level, Harrisburg, PA 17109 Phone: 717-724-6740 Fax: 717-724-6741 | |
Abimbola O Orisamolu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Londonderry Rd Lowr Level, Harrisburg, PA 17109 Phone: 717-724-6740 Fax: 717-724-6741 | |
Mark R Labuski, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4518 Union Deposit Rd, Harrisburg, PA 17111 Phone: 717-652-5840 Fax: 717-652-8152 | |
Dean M Brockmole, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4518 Union Deposit Rd, Harrisburg, PA 17111 Phone: 717-652-5840 Fax: 717-652-8152 |